Anne-Marie Dingemans

Trials

Studies that name Anne-Marie Dingemans as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:07 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT05221372 · ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI)

  Erasmus Medical Center · recruiting · Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor · principal investigator
• Ph2
  NCT04127110 · Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

  European Organisation for Research and Treatment of Cancer - EORTC · active not recruiting · Non Small Cell Lung Cancer · principal investigator
• N/A
  NCT02501707 · Echocardiography for RILI Prediction

  Maastricht Radiation Oncology · terminated · NSCLC · principal investigator
• N/A
  NCT02284308 · Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

  Maastricht Radiation Oncology · active not recruiting · NSCLC · principal investigator
• Ph1
  NCT00522886 · Phase I Cetuximab and Concurrent Radio-chemotherapy

  Maastricht Radiation Oncology · completed · Non-small Cell Lung Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.